Gapping up
In reaction to strong earnings/guidance:
- CONN +1%
Other news:
- ALDX +55.5% (announces positive results from the Phase 3 ALLEVIATE Trial of 0.25% and 0.5% reproxalap topical ophthalmic solution in patients with allergic conjunctivitis -- trial met primary endpoint and key secondary endpoint for both concentrations of reproxalap)
- BBBY +19.7% (WSJ reported three activists are trying to replace the entire Board and the CEO; Raymond James also upgraded to Strong Buy this morning)
- SNE +2% (announces realignment of key businesses and executive appointments effective April 1)
- TSLA +1.8% (A Federal judge has dismissed a Tesla production lawsuit.)
- CELG +1.2% (submitted a New Drug Application to the FDA for ozanimod for the treatment of adults with relapsing forms of multiple sclerosis )
- BA +1.1% (will provide free software upgrades to airlines who purchased 737 Max plane)
- VALE +1% (announces court decision regarding freezing of funds)
- X +0.9% (following CNBC FastMoney mention)
- BMY +0.9% (Bristol-Myers/Celgene (CELG) receive request for additional information and documentary materials from the FTC in connection with pending merger)
- MEOH +0.8% (confirms it received notice from M&G Investment Management of intention to nominate 4 candidates for election to the Board) .
Analyst comments:
- INO +6.4% (initiated with Overweight at Cantor Fitzgerald)
- NVDA +2.3% (initiated with an Overweight at Piper Jaffray)
- NBEV +2.3% (initiated with a Buy at Alliance Global Partners)
- BBT +1.6% (upgraded to Buy from Hold at Deutsche Bank)
- AAPL +1% (tgt raised to $201 from $187 at Piper Jaffray)
- VRTX +0.9% (upgraded to Outperform from Mkt Perform at William Blair)